highly significantp = 0.002
Furthermore, within the nicergoline group, plasma substance P concentrations exhibited a highly significant post-treatment elevation ( p = 0.002) following the exclusion of the Parkinson’s cohort.
Furthermore, within the nicergoline group, plasma substance P concentrations exhibited a highly significant post-treatment elevation ( p = 0.002) following the exclusion of the Parkinson’s cohort.